Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Sarclisa-Containing Treatment Regimen Shows 'Remarkable' Results for Relapsed Myeloma Curetoday.com 2 days ago
2 Kyprolis: Side Effects, Uses, Dosage, and More Healthline 2 months ago
3 Kyprolis dosage: Form, strengths, how to use, and more Medical News Today 5 months ago
4 Kyprolis: Side Effects and How to Manage Them Healthline 6 months ago
5 FDA approves Kyprolis regimen for relapsed or refractory multiple myeloma Healio 6 months ago
6 Xpovio-Kyprolis Combo Shows Good Response in Hard-to-treat Myeloma Myeloma Research News 3 months ago
7 Elotuzumab Combination Disappoints in Newly Diagnosed Myeloma Medpage Today 7 days ago
8 BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma Business Wire 10 months ago
9 CRISPR Therapeutics (CRSP) Appoints Phuong Khanh Morrow as Chief Medical Officer StreetInsider.com 2 days ago
10 Dara-KRd in NDMM: Results From the MASTER Study Targeted Oncology 10 days ago
11 Kyprolis: Side effects, dosage, cost, use for multiple myeloma, and mo Medical News Today 2 years ago
12 FDA approves Darzalex Faspro, Kyprolis, and Dexamethasone for multiple myeloma The Cancer Letter 6 months ago
13 Kyprolis: Uses, Side Effects, Dosages, & Precautions Verywell Health 3 months ago
14 LIGAND PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) Marketscreener.com 9 days ago
15 FDA Approves New Kyprolis Combination Regimen – PharmaLive PharmaLive 2 years ago
16 Kyprolis Combo Shows Promise as Initial Therapy for Multiple Myeloma Myeloma Research News 3 years ago
17 FDA Approves Darzalex + Kyprolis for Relapsed or Refractory MM Clinical Oncology News 2 years ago
18 Kyprolis-Based Regimen Induces Similar Results as Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Curetoday.com 11 months ago
19 Once-a-week Kyprolis Effective for Untreated Multiple Myeloma Patients Myeloma Research News 3 years ago
20 Recap: Treatment Options in Transplant-Eligible and -Ineligible Multiple Myeloma Cancer Network 4 days ago
21 Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) Short Interest Update Defense World 15 hours ago
22 [Special] Kyprolis vs Ninlaro. The winner in MM treatment market is … KBR 1 year ago
23 FDA approves Sarclisa with Kyprolis for multiple myeloma The Pharma Letter 1 year ago
24 FDA's Approval of Subcutaneous Darzalex-Based Regimen Adds Another 'Tool in the Toolbox' to Treat Pretreated Myeloma Curetoday.com 5 months ago
25 KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer PR Newswire 2 years ago
26 FDA Approves Once-Weekly Kyprolis Regimen for Myeloma Curetoday.com 4 years ago
27 Long-term Data Confirms Kyprolis Survival Benefit in Relapsed... Myeloma Research News 5 years ago
28 Darzalex Faspro Combo Therapy for Myeloma Patients Approved by FDA Myeloma Research News 5 months ago
29 Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder (generic for Kyprolis®) PR Newswire 11 months ago
30 Amgen's Kyprolis fails in first-line myeloma BioPharma Dive 6 years ago
31 Carfilzomib (Kyprolis ): risk of reactivation of hepatitis B virus GOV.UK 2 years ago
32 Can Amgen's new-and-improved Kyprolis kick-start myeloma sales? FiercePharma 4 years ago
33 Kyprolis Duo Improves Survival in Multiple Myeloma Curetoday.com 5 years ago
34 Kyprolis Combo Fails to Outperform Velcade for Multiple Myeloma... Myeloma Research News 6 years ago
35 Myeloma Combo Reolysin-Kyprolis Shows Promising Responses in Trial Myeloma Research News 2 years ago
36 Reolysin, Kyprolis Combo for Myeloma the Focus of Recent Expert Call Myeloma Research News 2 years ago
37 Amgen's myeloma treatment Kyprolis gains NICE approval pharmaphorum 5 years ago
38 Inside the Clinic: JTCC Experts Highlight Pivotal Ongoing Trials in Multiple Myeloma OncLive 2 months ago
39 Preferences for Managing Relapsed Multiple Myeloma Cancer Network 3 months ago
40 Subcutaneous Daratumumab Plus Kd Is a “Gamechanger” for Patients With Multiple Myeloma OncLive 4 months ago
41 Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study Reuters 5 years ago
42 Most influential people in biopharma, the scientists FiercePharma 9 days ago
43 Sarclisa Triple Combo Prolongs Life Without Disease Progression in... Myeloma Research News 2 years ago
44 SMC gives green light for Amgen's Kyprolis PMLiVE 5 years ago
45 Velcade-Based Triplet Regimen 'Should Remain' Standard of Care in Newly Diagnosed Multiple Myeloma Curetoday.com 2 years ago
46 FDA Approves Once-Weekly Dose of Kyprolis for R/R Multiple Myeloma AJMC.com Managed Markets Network 4 years ago
47 Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma PR Newswire 7 years ago
48 Progression-Free Survival and Minimal Residual Disease Negativity May Result From Combination Therapy in Newly Diagnosed Multiple Myeloma Curetoday.com 1 year ago
49 KRd Plus Lenalidomide Maintenance Yielded Positive MRD- CRs and May Delay End-Organ Disease in High-Risk Smoldering Myeloma Cancer Network 7 months ago
50 20 Years of Advancements Brings a 'Luxury' of Treatment Options for Patients With Myeloma Curetoday.com 2 months ago
51 New Drug Combination for Unresponsive Multiple Myeloma Needs a Closer Look Curetoday.com 6 years ago
52 Navigating Individual Treatment for Relapsed/Refractory Multiple Myeloma Cancer Network 5 months ago
53 FDA Approves Isatuximab Plus Carfilzomib/Dexamethasone for Relapsed/Refractory Multiple Myeloma OncLive 1 year ago
54 Daratumumab-Led Quad Therapy Aids MRD Surveillance in MM AJMC.com Managed Markets Network 5 months ago
55 Luciano Costa, MD, PhD, Discusses Topline Data Utilizing KRd in Newly Diagnosed Myeloma Cancer Network 8 months ago
56 Myeloma Prevented With Kyroplis Combo, Stem Cell Transplant, Data Say Myeloma Research News 2 years ago
57 $332.26 Million in Sales Expected for BeiGene, Ltd. (NASDAQ:BGNE) This Quarter Defense World 3 days ago
58 Darzalex (daratumumab): Side effects, cost, dosage, and more Medical News Today 2 years ago
59 Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting Yahoo Finance 2 months ago
60 Luciano Costa, MD, PhD, Shares Key Takeaways From the MASTER Trial in Multiple Myeloma Cancer Network 7 months ago
61 Myeloma Study Finds Pomalyst More Cost-Effective Than Two Rivals Myeloma Research News 5 years ago
62 AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS PR Newswire 3 months ago
63 Tweet Chat Recap: Evolving Options for Newly Diagnosed Multiple Myeloma Targeted Oncology 9 months ago
64 Amgen Inc. (NASDAQ:AMGN) Plans Quarterly Dividend of $1.94 Defense World 5 days ago
65 FDA Approval Insights: Isatuximab Plus Carfilzomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma OncLive 9 months ago
66 Second indication of Sarclisa for relapsed MM approved by EC The Pharma Letter 1 year ago
67 Daratumumab Plus KRd Regimen for Myeloma Results in Favorable MRD Negativity Rates Cancer Network 1 year ago
68 Iberdomide Combination Shows Promise and Tolerability in Multiple Myeloma OncLive 8 months ago
69 Part 1: Benefit Shown With Transplant and Combination Therapy in Multiple Myeloma Targeted Oncology 4 months ago
70 Once-Weekly Carfilzomib Regimen Approved by the FDA for Myeloma Targeted Oncology 4 years ago
71 Triplet Regimen Options Reviewed for Multiple Myeloma Targeted Oncology 10 months ago
72 Combinations Offer Multiple Treatment Options in Relapsed/Refractory Multiple Myeloma Targeted Oncology 7 months ago
73 Costa Reviews Regimens for Patients With Transplant-Eligible and Transplant-Ineligible NDMM Targeted Oncology 2 months ago
74 Transplant-Ineligible Multiple Myeloma: Triplet vs Quadruplet Therapy Cancer Network 3 months ago
75 Costa Breaks Down Treatment Options for Patients With Multiple Myeloma Targeted Oncology 6 months ago
76 Part 1: Selecting Treatment Options for Relapsed/Refractory Multiple Myeloma Targeted Oncology 4 months ago
77 New myeloma meds offer improvement, but are far too expensive: Report FiercePharma 6 years ago
78 Why Amgen, Inc.'s Kyprolis FOCUS Failure Is a Big Deal The Motley Fool 8 years ago
79 Frontline Use of Daratumumab-Based Regimens in Transplant-Ineligible MM AJMC.com Managed Markets Network 4 months ago
80 Novel Agents Help Bridge Gaps in Care in Multiple Myeloma OncLive 5 months ago
81 Dr. Hari on the Role of Carfilzomib, Pomalidomide, and Dexamethasone in R/R Myeloma OncLive 1 year ago
82 Velcade (bortezomib): Side effects, uses, cost, and more Medical News Today 2 years ago
83 Amgen 2021: Breakaway potential – PharmaLive PharmaLive 7 months ago
84 Three-Drug Combination Improves Progression-Free Survival in Patients with Multiple Myeloma Curetoday.com 2 years ago
85 Experimental Treatments for Myeloma Myeloma Research News 7 months ago
86 HALOZYME THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) Marketscreener.com 8 days ago
87 Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients PharmaTimes 10 months ago
88 Selinexor Approved in China for Relapsed or Refractory Multiple Myeloma OncLive 5 months ago
89 Fonseca on Findings for First- Vs Second-Line Daratumumab for Transplant-Ineligible Myeloma Cancer Network 4 months ago
90 Promising Developments in Treating Multiple Myeloma Coming at This Year’s AACR Meeting Baystreet.ca 2 months ago
91 Multiple myeloma relapse: Signs, diagnosis, and outlook Medical News Today 6 months ago
92 Dr Joshua Richter Explains Importance of Cytogenetics in Multiple Myeloma AJMC.com Managed Markets Network 4 months ago
93 Surgical Staging Affects Some QOL Scores in Early Breast Cancer Cancer Therapy Advisor 5 months ago
94 Selinexor Combo Leads to Strong, Durable Responses in RRMM Patients Myeloma Research News 3 years ago
95 New Analysis Confirms Carfilzomib Survival Benefit in Relapsed/Refractory Myeloma OncLive 4 years ago
96 FDA gives full approval to Amgen blood cancer drug Reuters 6 years ago
97 real-world data confirms that carfilzomib, lenalidomide, and dexamethasone are a safe and effective option for patients with relapsed or refractory multiple myeloma AJMC.com Managed Markets Network 1 year ago
98 NICE rebuffs J&J's Darzalex price for newly diagnosed myeloma but leaves negotiation door open FiercePharma 9 months ago
99 Sanofi (SNY), Blackstone Ink Deal for Subcutaneous Sarclisa Nasdaq 2 months ago
100 FDA approves Onyx blood cancer drug Kyprolis Fox News 7 years ago